Literature DB >> 8461033

Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes.

J Mäenpää1, H Sigusch, H Raunio, T Syngelmä, P Vuorela, H Vuorela, O Pelkonen.   

Abstract

Coumarin is 7-hydroxylated by the P450 isoform Cyp2a-5 in mice and CYP2A6 in humans. Various drugs, endogenous substances, plant substances and carcinogens, altogether about 90 chemicals, were evaluated as possible inhibitors of coumarin 7-hydroxylase (COH) activity in mouse microsomes. The effects of selected compounds on COH activity in human liver microsomes were also tested. The furanocoumarin derivatives methoxsalen (8-methoxypsoralen) and psoralen proved to be the most potent inhibitors of mouse COH activity (IC50 values 1.0 and 3.1 microM, respectively). The furanocoumarins bergapten (5-methoxypsoralen), isopimpinellin (5,8-dimethoxypsoralen), imperatorin and sphondin also effectively inhibited mouse COH activity (IC50 values 19-40 microM). Methoxsalen, isopimpinellin and metyrapone were also inhibitors in mice in vivo. Methoxsalen was a potent inhibitor of COH activity also in human liver microsomes, (IC50 value 5.4 microM), whereas bergapten, isopimpinellin and imperatorin had no effect. The imidazole antimycotic miconazole was a potent but non-specific inhibitor of COH activity. Several known substrates and inhibitors of members in the CYP1A, CYP2B, CYP2C, CYP2D and CYP3A subfamilies were poor inhibitors of COH activity. These results suggest that (i) the coumarin-type compounds in particular interact with the active sites of Cyp2a-5 and CYP2A6, and (ii) the active sites of Cyp2a-5 and CYP2A6 are structurally different, since a number of compounds inhibited mouse, but not human COH activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461033     DOI: 10.1016/0006-2952(93)90247-t

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

Review 1.  Polymorphisms of CYP2A6 and its practical consequences.

Authors:  H Raunio; A Rautio; H Gullstén; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 2.  Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.

Authors:  T Yokoi; T Kamataki
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

3.  Bioactivation of the tobacco carcinogens 4-aminobiphenyl (4-ABP) and 2-amino-9H-pyrido[2,3-b]indole (AαC) in human bladder RT4 cells.

Authors:  Medjda Bellamri; Lihua Yao; Radha Bonala; Francis Johnson; Linda B Von Weymarn; Robert J Turesky
Journal:  Arch Toxicol       Date:  2019-06-15       Impact factor: 5.153

4.  Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin.

Authors:  U S Svensson; M Ashton
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 5.  Regulation of coumarin 7-hydroxylation in man.

Authors:  O Pelkonen; A Rautio; H Raunio; J Mäenpää; J Hakkola
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  Celery extract inhibits mouse CYP2A5 and human CYP2A6 activities via different mechanisms.

Authors:  Xiao Deng; Qianghong Pu; Erhao Wang; Chao Yu
Journal:  Oncol Lett       Date:  2016-10-25       Impact factor: 2.967

7.  Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway.

Authors:  Yongke Lu; Xu Hannah Zhang; Arthur I Cederbaum
Journal:  Toxicol Sci       Date:  2012-05-02       Impact factor: 4.849

8.  Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.

Authors:  Y Li; N Y Li; E M Sellers
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

9.  Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.

Authors:  Jaime D'Agostino; Xiuling Zhang; Hong Wu; Guoyu Ling; Suping Wang; Qing-Yu Zhang; Fucai Liu; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2008-07-31       Impact factor: 3.922

10.  Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6.

Authors:  T Kinonen; M Pasanen; J Gynther; A Poso; T Järvinen; E Alhava; R O Juvonen
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.